David Sommerhalder
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 25
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 6
- Colorectal Cancer Treatments and Studies 5
- Co-authors
- Rodney E. Shackelford (1 shared paper)Prakash Peddi (1 shared paper)Amol Takalkar (1 shared paper)Minal Barve (5 shared papers)Alexander I. Spira (7 shared papers)David S. Hong (5 shared papers)Allison Reed (1 shared paper)Kevin J. Freise (3 shared papers)
- Journals
- Journal of Clinical Oncology (21 papers)Annals of Oncology (7 papers)Cancer Research (6 papers)Molecular Cancer Therapeutics (1 paper)npj Precision Oncology (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
David Sommerhalder
39 papers receiving 178 citations
Peers
Comparison fields: 5 of 29
- Oncology 67
- Hepatology 11
- Pulmonary and Respiratory Medicine 44
- Immunology 27
- Molecular Biology 87
Countries citing papers authored by David Sommerhalder
This map shows the geographic impact of David Sommerhalder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sommerhalder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sommerhalder more than expected).
Fields of papers citing papers by David Sommerhalder
This network shows the impact of papers produced by David Sommerhalder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sommerhalder. The network helps show where David Sommerhalder may publish in the future.
Co-authors
The 25 scholars most cited alongside David Sommerhalder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 22 | |
| 2 | 2025 | 20 | |
| 3 | 2021 | 10 | |
| 4 | 2022 | 9 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 9 | |
| 7 | 2024 | 8 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 6 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2025 | 4 | |
| 18 | 2023 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2023 | 3 |
About David Sommerhalder
David Sommerhalder is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Immunology, having authored 48 papers that have together received 186 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Research and Treatments (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). The work is most often cited by research in Oncology (67 citations), Hepatology (11 citations), Pulmonary and Respiratory Medicine (44 citations), Immunology (27 citations) and Molecular Biology (87 citations). David Sommerhalder has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Rodney E. Shackelford, Prakash Peddi, Amol Takalkar, Minal Barve, Alexander I. Spira, David S. Hong, Allison Reed, Kevin J. Freise, Manish Sharma and Noboru Yamamoto. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Molecular Cancer Therapeutics and npj Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.